Gregory Fiore MD
President and Chief Executive Officer
Dr. Fiore is a Co-Founder and is the President and Chief Executive Officer of Sollis Therapeutics. He is an entrepreneur and founder of two successful healthcare consulting firms, Fiore Healthcare Advisors and SSI Strategy. Dr. Fiore was previously Chief Medical Officer at The Medicines Company, a global biopharmaceutical company focused on hospital products. He has held leadership roles at Merck and Abbott Laboratories and previously worked as a Strategy Consultant at McKinsey & Company.
Dr. Fiore completed Internal Medicine internship and residency at Harvard Medical School’s Brigham and Women’s Hospital and received clinical training in Pulmonary & Critical Care Medicine at Harvard Medical School. He received his MD degree and was valedictorian at New York Medical College and received a B.S. degree in Zoology from the University of Rhode Island with honors.
Dr. Fiore serves on several Medical and Business Advisory Committees. He is on the Executive Board of the Institute of Neuromodulation (ION), the Scientific Advisory Board for Advera Health Analytics, the Business Advisory Board for the Advanced Group of Companies, the Editorial Advisory Board of Clinical Leader, and the Executive Committee for the Safety of Oral Anticoagulants (SOAR) Registry and serves as the Lead Medical Advisor for Synspira, Inc. a privately held biotechnology company. He has previously served on the Board of Dubset Media Holdings.
Bryan Jones PhD
Chief Operating Officer
Dr. Jones is a Co-Founder is the Chief Operating Officer of Sollis Therapeutics. He has more than 25 years of experience with Biotech and Specialty Pharmaceutical companies with specific expertise in Business and Product development. Prior to Sollis, he was a Vice President at Sorrento Therapeutics where he led development of a neuraxially administered neuroablative compound for treatment of chronic pain and neurogenic inflammation. While there, Dr. Jones led the creation of ARK Animal Health, an animal health subsidiary company.
Previously he was Chief Operating Officer at Sherrington Pharmaceuticals and Mt. Cook Pharma as well as Vice President at Kemia, Inc. Earlier in his career, Dr. Jones held executive roles in Business Development at Amylin Pharmaceuticals and in Research at Bristol-Myers Squib.
Dr. Jones received his B.S. in biology with a concentration in biochemistry from Iowa State University and holds a Ph.D. in genetics from the University of Washington.
Megan Stojic PharmD
Director of Clinical Operations
Dr. Stojic joined Sollis Therapeutics in 2018 as the Director of Clinical Operations. She brings more than a decade of clinical trials oversight experience from West-Ward Pharmaceuticals / Roxane Laboratories. In roles of increasing responsibility she was responsible for design and execution of multiple clinical programs and oversaw multiple successful NDA and ANDA applications leading to marketing approval.
She is a licensed pharmacist and received her Pharm.D. degree from Ferris State University. She completed a post-doctoral Clinical Pharmacy Residency at Ohio State University Medical Center.